Bristows' patent litigation experts, Brian Cordery and Adrian Chew will be joined by 8 New Square barrister, Charlotte May KC on Wednesday 26 February 2025 for an engaging fireside chat, as they explore the evolving concept of plausibility in patent law.
Calling all oncology startup founders! Fancy winning £50,000-worth of resources like lab space and tailored support? Last chance to apply for the fantastic Discovery Spark accelerator programme:
💡 Work with expert mentors to refine your strategy and storytelling
🌐 Join a network of founders and industry leaders
🏆 Compete for resources like free lab space and tailored support worth over £50,000
Apply now: https://lnkd.in/ew_wSHgf
Negotiating commercial contracts can be complex. This session will show you how to get by without repeated phone calls to your lawyer…. And knowing when to ask for help. The session, led by Simon Portman, Of Counsel at Marks & Clark, will cover:
Negotiating strategies.
Different business cultures in terms of:
Universities.
SMEs.
Big multinationals.
Nationality.
Dangers of relying on precedents and AI-generated material.
Common pitfalls.
Making the best use of advisors.
BioTrinity, now in its 19th year, is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference programme for 2025 features a dual track of showcase presentations from R&D companies at around the Series A stage, across 14 different therapy areas, a packed business & investment track, sponsors exhibition, networking events, private partnering meetings and an academic poster presentation. View the current programme
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
Function, Focus area, Location
Job type: Full-time
Location: Oxford, with hybrid working options available
Salary: Competitive salary
Right to work: Sponsorship available
Corning Scientific Webinar
Organoids are 3D cellular models derived from pluripotent and adult stem cells, that mimic specific organs or tissues. Growth factors and extracellular matrices (ECM) support their self-renewal and differentiation. Used for various applications, including organ and tissue characterization, patient-derived organoids offer accurate models for personalized treatment, better representing the in vivo microenvironment compared to 2D cultures.
London, January 28, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for ICR Healthcare and is pleased to announce the placement of Sarah Elton-Farr as Partner, effective April 2025.